Posts

Showing posts with the label Blogpost727

First Time Generic Approvals – USFDA 2022 – Asrar Qureshi’s Blog Post #727

Image
First Time Generic Approvals – USFDA 2022 – Asrar Qureshi’s Blog Post #727 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #727 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Pavel Danilyuk New products are the lifeline of pharmaceutical companies all over the world. Most new products are developed in the US, or by the US-based companies who may do research elsewhere. Japan is also credited with new molecules introduction. Europe has gone far behind in this process. European companies have either shifted their base to the US or are collaborating with the companies there to come up with new research products. Rest of the world is contented with the generics business. Pakistan is the same. The local corporates keep looki...